Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Devon Energy Corp (DVN) vs Nuwellis Inc (NUWE) Price & Performance

Devon Energy CorpTrade
Nuwellis IncTrade

Price performance (Past 24H)

Key statistics

Devon Energy Corp vs Nuwellis Inc — how do they compare? Devon Energy Corp trades at $42.46 (market cap $50.44B), while Nuwellis Inc trades at $3.2 (market cap $1.17M). The key difference: Devon Energy Corp is far larger — about 43111.1× Nuwellis Inc's market cap, and Devon Energy Corp pays a 2.38% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.

DVNNUWE
Market Cap
$50.44B$1.17M
Sector
EnergyTechnology
52-Week High
$52.07$558.26
52-Week Low
$31.74$2.80
Enterprise Value
$57.22B-$636.97K
Dividend Yield
2.38%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Devon Energy Corp

Devon Energy (DVN) trades at $43.73, up 3.55% on the day, with a bullish technical signal and strong analyst consensus. Recent earnings show mixed results, beating in Q3 and Q4 2025 but missing in Q1 2026, with Q2 results pending. The company maintains solid profitability with a 13.71% net margin and robust cash flow, supported by the Coterra acquisition targeting $2 billion in synergies by 2027. Debt-to-asset ratio improved to 26.54% in 2025, reflecting disciplined financial management.

Outlook remains positive with a consensus price target of $60.55, implying significant upside. Key opportunities include synergy realization and free cash flow growth, while risks involve oil price volatility and activist investor pressure for asset sales. The stock offers value with a P/E of 12.18, below sector averages, but investors should monitor Q2 earnings due August 4 for confirmation of growth trajectory.

Nuwellis Inc

NUWE trades at $2.80, down 7.89% in the last session, with a bearish technical outlook. The company reported a net loss of $17.52M in 2025 despite $8.27M revenue, reflecting negative profit margins and cash flow challenges. Recent news highlights expansion in pediatric care and a $6M public offering closed in June 2026, alongside a CEO transition to Mike McCormick effective June 30, 2026.

Outlook remains high-risk due to persistent losses and cash burn, though analyst consensus is split evenly between Buy and Hold. Key risks include execution in revenue growth and reliance on financing. Upside depends on successful commercialization of Aquadex therapy and FDA label expansion for pediatric patients.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Devon Energy Corp

Devon Energy, based in Oklahoma City, is one of the largest independent exploration and production companies in North America. The firm's asset base is spread throughout onshore North America and includes exposure to the Delaware, STACK, Eagle Ford, Powder River Basin, and Bakken plays. At year-end 2021, Devon's proved reserves totaled 1.6 billion barrels of oil equivalent, and net production that year was 572 thousand boe/d, of which oil and natural gas liquids made up 74% of production, with natural gas accounting for the remainder.

Read more on DVN

About Nuwellis Inc

Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.

Read more on NUWE